Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hypofractionated Radiotherapy Combined With Thymosin for Metastatic NSCLC
NCT02787447Phase 2Unknown
- Sponsor
- Hangzhou First People's Hospital
- Start
- May 2016
- Primary completion
- Dec 2017
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of thymosin alpha 1 in lung adenocarcinoma, sponsored by Hangzhou First People's Hospital. Status: unknown.
02
Drugs
thymosin alpha 1
03
Conditions
lung adenocarcinoma
Beyond the preview
Go deeper on NCT02787447.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02787447.